Fatal familial insomnia (FFI) is a rare prion disease first described by Lugaresi et al., in 1986 1 . The prevalence of FFI is one case per a million population per year, with only about 57 cases in 27 kindreds have been reported worldwide 2 . FFI is an autosomal dominant disease that harbors a missense GAC to AAC mutation at codon 178 of the PRNP prion protein gene located on chromosome 20, along with the presence of the methionine polymorphism at position 129 of the mutant allele 3, 4 . Pathologically, FFI is characterized by predominant thalamic degeneration especially in the medio-dorsal and anterio-ventral nuclei 5, 6 . Phenotypic variability is a perplexing feature of FFI. FFI is mainly characterized by prominent sleep impairment combined with neuropsychiatric disorders, dysautonomia and motor dysfunction 7 . Polysomnography (PSG) recordings document the biophysiological changes that occur during sleep. In FFI, PSG has disclosed a severely reduced total sleep time, reduced rapid eye movement (REM) sleep and abnormal stage shifts. In some cases, FFI was characterized by the lack of REM-associated muscle atonia and the presence of jerky activity of limb muscles and irregular breathing 8 . Irregular breathing, hypnic jerks, propriospinal myoclonus at the wake-sleep transition, and quasi-purposeful limb gestures are considered to be characteristic features of FFI 6, 7 . Further, husky voice was reported in 22% of FFI patients in Germany 9 . Nevertheless, the mechanism and diagnostic value of sleep related respiratory disturbance and movement disorder in FFI have not been studied thoroughly yet. Here, we have analyzed the clinical manifestations and biological changes, especially the sleep related symptoms, PSG and brain imaging results of five Chinese patients diagnosed with FFI. This study aims to understand the pathogenesis of sleep related disorders in FFI.
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Familial medical history and genetic analysis. Patients 1 and 2 were siblings, and interviews with family members have noted that their mother and an elder brother had similar FFI symptoms. Furthermore, the mother of Patient 5 died at the age of 70 years old due to rapid progressive dementia (RPD). The other two patients (Patients 3 and 4) had no known family history.
Gene sequencing of DNA extracted from the peripheral blood leukocytes revealed that all five patients had a D178N mutation with methionine/methionine homozygosity at the polymorphic 129 codon of the PRNP gene. Seven family members of Patients 1 and 2 were screened for PRNP gene mutation. Other family members were not screened due to lack of consent or prior death. Results of the screened family members demonstrated that the healthy control subjects number II-6, III-6, III-11, III-13, and III-14 were free of the PRNP D178N mutation and subjects number III-10 and III-15 were clinically healthy carriers of the PRNP D178N mutation (Fig. 1) . Patient 3's mother was also screened for PRNP gene mutation, and she was also a carrier of the D178N mutation without displaying the clinical FFI symptoms (data not shown).
The expression of 14-3-3 protein, EEG analysis, and brain imaging. ELISA results confirmed that all patients were negative for the CSF 14-3-3 protein, consistent with previous reports indicating that 14-3-3 protein is usually normal or nonspecifically changed in FFI 10 . EEG showed diffuse slow waves without periodic spike discharges in the five patients, and the brain MRI did not reveal any abnormalities (data not shown). SPECT performed on Patient 1 indicated a decline in blood perfusion of the bilateral thalamus, basal ganglia, and the medial temporal lobe (Fig. 2) . Furthermore, MRS analysis for Patient 1 showed a declined level of N-aceytl aspartate (NAA) in the left thalamus (data not shown). Patient 2 underwent a PET scan, which demonstrated decreased glucose uptake in the left thalamus and bilateral inferior parietal lobe (Fig. 3) . PSG analysis shows signs of sleep-related respiratory disturbance and leg-movement. All five patients enrolled in this study underwent PSG. The results demonstrated an early reduction in the sleep spindles and K complexes, a drastic reduction in the total sleep time by about 50% (average total sleep amounts = 212.3 ± 26.6 minutes), and decreased sleep efficiency. In addition, disruptions of the normal cyclic sleep organization, especially the loss or decreased ratio of REM phase and prolonged sleep latency of REM were also detected. In Patient 3, REM sleep occurred directly from wakefulness. The PSG indices for sleep efficiency and sleep organization are listed in Table 2 . Moreover, PSG identified sleep apnea syndrome in all FFI patients, characterized by obstructive apnea/hypopnea and laryngeal stridor in the NREM stage. We observed involuntary movements in these five patients during sleep, mostly during the NREM stage 2. We did not detect PLMS. The PSG indices for sleep-related respiratory disturbance and leg-movement are listed in Table 3 .
Hypnogram analysis. Finally, the hypnogram analysis for the five FFI patients has revealed a decreased sleep efficiency and disruption of the normal cyclic sleep organization. In contrast, the healthy control participants successfully completed several sleep cycles (Fig. 4) . Figure 1 . The pedigree of case 1(II-7) and case 2(II-9). II-7 is the proband of this pedigree (arrow). II-7 and II-9 are respectively Patient 1 and Patient 2 who carried PRNP D178N mutation. Additionally, seven family members were screened for PRNP gene mutation: II-6, III-6, III-11, III-13, and III-14 were healthy participant free of PRNP D178N mutation; III-10 and III-15 were clinically healthy carriers of the PRNP D178N mutation.
Other family members were not screened due to lack of consent or prior death. 
Discussion
FFI is a rare fatal genetic disease that affects both genders equally. The mean age at disease onset is approximately 50 years (range, 21-62 years), and the FFI duration varied from 7 to 72 months 7, 11 . Increased insomnia and sleep-wake cycle disruption are the clinical hallmarks of FFI. In this study, we reported the clinical aspects as well as the analysis of sleep cycle and sleep-related disturbances for five Chinese Han patients. We have compared symptoms of Chinese FFI patients with FFI patients reported from other countries, especially those from Italy and Germany, and no major differences were found. Patient 3 had an early onset of FFI at the age of 19 years. To the best of our knowledge, this is the youngest FFI patient ever reported. Genetic analysis of the PRNP gene confirmed that Patient 3's mother was a healthy carrier of the D178N mutation, suggesting that PRNP gene mutation may have an autosomal dominant trait with incomplete penetrance. The alterations in the sleep cycle in the five FFI cases were investigated by PSG recording. All patients showed a declined sleep efficiency and disruption of the cyclic sleep organization. The recording revealed abortion of the REM sleep or reduction of REM and increased latency to reach the REM stage. Furthermore, PSG results revealed an early reduction in the sleep spindles and K complexes in our patients, and these results came in accordance with previous studies [1] [2] [3] . Sleep spindles and K-complexes indicate the transition from light to deep NREM sleep. It has been confirmed that sleep spindles are produced by the thalamus 12 . Therefore, the loss of the sleep spindles and K-complexes suggests a decline in thalamic function 8 . In this study, we discovered characteristic sleep features that were rarely reported in previous FFI cases, i.e., sleep apnea syndrome, laryngeal stridor, and sleep-related involuntary movements. In good agreement with these clinical symptoms, PSG recorded obstructive apnea/hypopnea, laryngeal stridor, and NREM stage 2 involuntary movement in the five patients enrolled in this study. Therefore, it is plausible to speculate that active laryngeal narrowing during inspiration led to the development of obstructive apnea/hypopnea and laryngeal stridor in patients with FFI. The paralysis of the posterior cricoarytenoid muscle was reported to cause passive laryngeal narrowing producing the inspiratory stridor 13 . In the five cases enrolled in this study, we did not observe PLMS events; Table 3 . Sleep-related respiratory disturbance and leg-movement indices of the five FFI patients. AHI: apnea/ hypopnea index; PLMS: periodic leg movement in sleep; +: symptom/sign observed; −: symptom/sign not observed. however, we noticed involuntary limb movements, especially in NREM stage 2. This result came in accordance with previous studies that reported hypnic jerks, quasi-purposeful limb gestures, and propriospinal myoclonus atypical to the NREM stage 2, 6, 7 . It was proposed that the abnormal involuntary movements during sleep were attributed to the thalamus 14, 15 . The histopathological hallmark of FFI is severe neuronal loss and deposition of the pathogenic prion protein (PrP Sc ) 16 . Previous postmortem neuropathological studies revealed severe atrophy of the thalamus, particularly in the anteroventral and dorsomedial thalamic nuclei, and the inferior olives 5, 6 . Additionally, moderate atrohpy of the cortex and basal ganglia were previously observed in FFI cases 17 . In this study, routine imaging of the brain did not reveal characteristic FFI features except for variable degrees of cerebral and cerebellar atrophy. Flourodeoxyglucose ( 18 F) PET scan uncovered a profound bilateral thalamus with less pronounced cingular hypometabolism compared with the FFI signature image 18, 19 . In accordance with previously published data, the SPECT scan of Patient 1 and PET scan of Patient 2 in our study confirmed hypometabolism in the thalamus. Bar et al. previously reported that hypometabolism was confined to the thalamus in the earlier stages of the disease 18 . Previous histopathological studies indicated severe neuronal loss in the thalamus 17 . Therefore, it was hypothesized that the dysregulation of the sleep-wake cycle is attributed to thalamic lesions 20 . However, animal studies showed that the thalamus is not critical or necessary for sleep-wake regulation 21 . Although thalamic strokes may cause hypersomnance, further analysis suggested that those strokes often extend to the hypothalamus and midbrain, which interferes with the ascending arousal projections. We speculate that basal ganglia-cortex circuits may also be involved in the regulation of the sleep-wake cycle. In this study, SPECT and PET scans revealed that basal ganglia and the cerebral cortex were affected in FFI. Furthermore, results obtained from rat models with induced lesions revealed that the basal ganglia are necessary for sleep architecture 22, 23 . In conclusion, in this study, we analyzed the clinical features and sleep patterns of five FFI cases. We observed decreased sleep efficiency and disruption of the normal cyclic sleep organization. Nevertheless, this study had a few limitations like the small number of examined cases and the absence of histopathological data. In future studies, we will include a larger number of FFI cases, perform a detailed histopathological study, and use MRS, SPECT, and PET scans to elucidate the mechanism of FFI.
Materials and Methods
Ethics Statement. This study protocols outlined in this manuscript were approved by the Ethics Committee and local Institutional Review Board (IRB) of Xuan Wu Hospital, Capital Medical University, Beijing. All methods and experiments were performed in accordance with the relevant guidelines and regulations. All patients and healthy participants enrolled in the study signed an informed written consent specifically approved for this study prior to the study commence.
Subjects. This was a retrospective study that included five Chinese patients of Han descent who had been diagnosed with FFI and admitted to Xuan Wu Hospital (Beijing) from 2009 to 2014. The patients were diagnosed according to the FFI diagnosis criteria mentioned previously 9 . The clinical and phenotypic features of FFI were recorded for each patient at the time of admission.
Genetic and biochemical analysis for 14-3-3 protein epxression and PRNP gene mutation. Blood samples were obtained from all patients as well as several healthy control family members of the sibling patients #1 and #2 and patient's #3 mother. PRNP gene mutation was detected in DNA isolated from the peripheral blood leukocytes as previously detailed 16, 24 . The 14-3-3 protein analysis was performed on cerebrospinal fluid samples by enzyme-linked immunosorbent assay (ELISA; Beijing TIANGEN) following the manufacturer's protocol as described previously 25 . EEG and brain imaging. EEG Statistical analysis. In this study, the SPSS software was used to evaluate statistical significance. Differences in measured variables were assessed by using Student's t test or Wilcoxon rank-sum test with nonparametric data. Results were considered statistically significant at P < 0.05.
